Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticlePractice

Hepatitis E infection during pregnancy

Shahnaz A. Chaudhry, Natasha Verma and Gideon Koren
Canadian Family Physician July 2015, 61 (7) 607-608;
Shahnaz A. Chaudhry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natasha Verma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gideon Koren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Question Many of my patients are from Southeast Asia where hepatitis E virus (HEV) infection is quite common. What precautions can I suggest they take before traveling to these areas and what is the risk of contracting HEV during pregnancy?

Answer Hepatitis E is a water-borne pathogen transmitted by the fecal-oral route. To reduce the risk of contracting HEV while traveling to endemic areas, it is important to maintain hygienic practices such as hand washing with safe water, particularly before handling food, avoiding drinking water or using ice cubes of unknown purity, and avoiding eating unpeeled fruits and vegetables. Currently there is no vaccine available in Canada for HEV. Hepatitis E infection during pregnancy, especially in the third trimester, is characterized by a more severe infection that sometimes results in fulminant hepatitis, increasing maternal and fetal mortality and morbidity.

Hepatitis E virus (HEV) is an emerging infectious agent causing acute viral hepatitis worldwide.1 Each year more than 20 million estimated cases of HEV infection occur globally, resulting into 70 000 deaths.1 Hepatitis E virus was first recognized in 1978 during an epidemic in Kashmir Valley in northern India, with 52 000 cases of hepatitis resulting in 17 000 deaths.2

Hepatitis E is a single-stranded RNA virus with 4 genotypes, of which genotypes 1 and 2 exclusively infect humans and can lead to endemic HEV or outbreaks in countries with poor sanitation systems. Genotypes 3 and 4 can infect humans, pigs, and other animals, and can result in sporadic infection in both developed and developing countries.3 Distribution of HEV varies across the globe, with genotype 1 being more common in Asia, Africa, and Latin America, while genotype 2 is more common in sub-Saharan Africa and Mexico. Genotypes 3 and 4 can infect both medically vulnerable and healthy populations, and are mostly detected in sporadic cases in developed countries.4,5

There is increasing evidence that HEV is an important contributor to maternal morbidity and mortality in South Asia, especially if infection occurs in the third trimester with genotype 1.6,7

Hepatitis E virus is a water-borne pathogen that has fecal-oral transmission, mostly due to ingestion of fecally contaminated water. Direct person-to-person transmission is uncommon.8 The incubation period ranges from 15 to 64 days with a mean of 6 weeks.9 The virus has a 50% rate of vertical transmission.7,10

During pregnancy

Hepatitis E infection during pregnancy and in the third trimester, especially with genotype 1, is associated with more severe infection and might lead to fulminant hepatic failure and maternal death.11–13 Although the mechanism of liver injury is not yet clear, it is possible that interplay of hormonal and immunologic changes during pregnancy, along with a high viral load of HEV, renders the woman more vulnerable.14 Immunologic changes during pregnancy promote the maintenance of the fetus in the maternal environment by suppression of T cell–mediated immunity, rendering pregnant women more susceptible to viral infections like HEV infection. During pregnancy, levels of progesterone, estrogen, and human chorionic gonadotropin increase as pregnancy advances. These hormones play a considerable role in altering immune regulation and increasing viral replications.15

Hepatitis E infection with genotype 1 during the third trimester can lead to maternal mortality in up to 15% to 25% of cases.16 Most of the studies showing high maternal mortality are from India, where infection occurs in epidemics. There is a very high risk of vertical transmission of HEV from the mother to the fetus. During a Delhi epidemic, a hospital-based study revealed that HEV infection during pregnancy was associated with miscarriage, stillbirth, or neonatal death in 56% of infants.6 One recent study1 highlights that HEV infection might be responsible for 2400 to 3000 stillbirths each year in developing countries, with many additional fetal deaths linked to antenatal maternal deaths.11 There is a very high risk of preterm delivery in pregnant women with HEV infection, with poor neonatal survival rates.11,17 In 2 separate studies from India, 15% to 50% of live-born infants of mothers with HEV infection died within 1 week of birth.11,18 During an outbreak in Sudan in 2010 to 2011, among 39 pregnant women with HEV infection there were 14 intrauterine deaths and 9 premature deliveries.19

Breastfeeding

Breastfeeding is considered safe in asymptomatic women infected with HEV despite the presence of anti-HEV antibodies and HEV RNA in the colostrum. However, it is considered unsafe if the mother has acute hepatic disease or an increased viral load. In these cases, feeding formula is advised, as there is a possibility of transmission from infected breast milk or lesions on the nipple through suckling.20,21

Prevention

Currently there is no commercially available HEV vaccine in North America. Hepatitis E vaccine using recombinant capsid protein has been shown in phase 2 and 3 clinical trials to be safe and effective in the general adult population.22,23 The recombinant hepatitis E vaccine, the first prophylactic vaccine against HEV infection, was approved in China in December 2011.24 Women traveling to HEV-endemic countries should strictly follow food and water precautions, such as drinking only bottled water, not adding ice cubes to beverages, avoiding unpeeled fruits and vegetables, and washing hands, fruits, and vegetables thoroughly with safe water before eating.25

Conclusion

Hepatitis E infection is a result of poor hygiene and can be prevented by practising good hygiene, handling food appropriately, and drinking safe water. Hepatitis E infection during pregnancy, especially in the third trimester with genotype 1, has a more severe outcome that might lead to fulminant hepatitis, increasing maternal and fetal mortality. It is relatively safe for women with hepatitis E infection to breastfeed, except for those with symptomatic HEV infection, for whom breastfeeding is not advisable.

Notes

MOTHERISK

Motherisk questions are prepared by the Motherisk Team at the Hospital for Sick Children in Toronto, Ont. Dr Chaudhry is a clinical pharmacology and toxicology fellow in the Motherisk Program. Dr Verma was an observer in the Motherisk Program. Dr Koren is the founder of the Motherisk Program.

Do you have questions about the effects of drugs, chemicals, radiation, or infections in women who are pregnant or breastfeeding? We invite you to submit them to the Motherisk Program by fax at 416 813-7562; they will be addressed in future Motherisk Updates. Published Motherisk Updates are available on the Canadian Family Physician website (www.cfp.ca) and also on the Motherisk website (www.motherisk.org).

Footnotes

  • This article is eligible for Mainpro-M1 credits. To earn credits, go to www.cfp.ca and click on the Mainpro link.

  • La traduction en français de cet article se trouve à www.cfp.ca dans la table des matières du numéro de juillet 2015 à la page e299.

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Rein DB,
    2. Stevens GA,
    3. Theaker J,
    4. Wittenborn JS,
    5. Wiersma ST
    . The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012;55(4):988-97.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Khuroo MS
    . Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011;161(1):3-14. Epub 2011 Feb 12.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Aggarwal R,
    2. Gandhi S
    . The global prevalence of hepatitis E virus infection and susceptibility: a systematic review. Geneva, Switz: World Health Organization; 2010.
  4. 4.↵
    1. Xia H,
    2. Wahlberg N,
    3. Belák S,
    4. Meng XJ,
    5. Liu L
    . The emergence of genotypes 3 and 4 hepatitis E virus in swine and humans: a phylogenetic perspective. Arch Virol 2011;156(1):121-4. Epub 2010 Oct 7.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Takahashi M,
    2. Nishizawa T,
    3. Yoshikawa A,
    4. Sato S,
    5. Isoda N,
    6. Ido K,
    7. et al
    . Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad. J Gen Virol 2002;83(Pt 8):1931-40.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Naidu SS,
    2. Viswanathan R
    . Infectious hepatitis in pregnancy during Delhi epidemic. Indian J Med Res 1957;45(Suppl):71-6.
    OpenUrlPubMed
  7. 7.↵
    1. Ornoy A,
    2. Tenenbaum A
    . Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol 2006;21(4):446-57. Epub 2006 Feb 9.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Khuroo MS
    . Viral hepatitis in international travellers: risks and prevention. Int J Antimicrob Agents 2003;21(2):143-52.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Wattré P
    . Hepatitis E virus [article in French]. Ann Biol Clin (Paris) 1994;52(7–8):507-13.
    OpenUrlPubMed
  10. 10.↵
    1. Khuroo MS,
    2. Kamili S,
    3. Jameel S
    . Vertical transmission of hepatitis E virus. Lancet 1995;345(8956):1025-6.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Patra S,
    2. Kumar A,
    3. Trivedi SS,
    4. Puri M,
    5. Sarin SK
    . Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007;147(1):28-33.
    OpenUrlCrossRefPubMed
  12. 12.
    1. Teo CG
    . Fatal outbreaks of jaundice in pregnancy and the epidemic history of hepatitis E. Epidemiol Infect 2012;140(5):767-87. Epub 2012 Jan 25.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Devi SG,
    2. Kumar A,
    3. Kar P,
    4. Husain SA,
    5. Sharma S
    . Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy. J Med Virol 2014;86(8):1366-76. Epub 2014 Mar 7.
    OpenUrlPubMed
  14. 14.↵
    1. Fiore S,
    2. Savasi V
    . Treatment of viral hepatitis in pregnancy. Expert Opin Pharmacother 2009;10(17):2801-9.
    OpenUrlPubMed
  15. 15.↵
    1. Navaneethan U,
    2. Al Mohajer M,
    3. Shata MT
    . Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008;28(9):1190-9. Epub 2008 Jul 25.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Ranger-Rogez S,
    2. Alain S,
    3. Denis F
    . Hepatitis viruses: mother to child transmission [article in French]. Pathol Biol (Paris) 2002;50(9):568-75.
    OpenUrlPubMed
  17. 17.↵
    1. Krain LJ,
    2. Atwell JE,
    3. Nelson KE,
    4. Labrique AB
    . Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection. Am J Trop Med Hyg 2014;90(2):365-70. Epub 2014 Jan 13.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Rasheeda CA,
    2. Navaneethan U,
    3. Jayanthi V
    . Liver disease in pregnancy and its influence on maternal and fetal mortality: a prospective study from Chennai, Southern India. Eur J Gastroenterol Hepatol 2008;20(4):362-4.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Rayis DA,
    2. Jumaa AM,
    3. Gasim GI,
    4. Karsany MS,
    5. Adam I
    . An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan. Pathog Glob Health 2013;107(2):66-8.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Kumar RM,
    2. Uduman S,
    3. Rana S,
    4. Kochiyil JK,
    5. Usmani A,
    6. Thomas L
    . Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001;100(1):9-15.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Chibber RM,
    2. Usmani MA,
    3. Al-Sibai MH
    . Should HEV infected mothers breast feed? Arch Gynecol Obstet 2004;270(1):15-20. Epub 2003 Apr 16.
    OpenUrlPubMed
  22. 22.↵
    1. Zhu FC,
    2. Zhang J,
    3. Zhang XF,
    4. Zhou C,
    5. Wang ZZ,
    6. Huang SJ,
    7. et al
    . Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376(9744):895-902.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Shrestha MP,
    2. Scott RM,
    3. Joshi DM,
    4. Mammen MP Jr.,
    5. Thapa GB,
    6. Thapa N,
    7. et al
    . Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356(9):895-903.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Wu T,
    2. Li SW,
    3. Zhang J,
    4. Ng MH,
    5. Xia NS,
    6. Zhao Q
    . Hepatitis E vaccine development: a 14 year odyssey. Hum Vaccin Immunother 2012;8(6):823-7. Epub 2012 Jun 1.
    OpenUrlPubMed
  25. 25.↵
    1. Committee to Advise on Tropical Medicine and Travel
    . Statement on travellers’ diarrhea. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2001;27:1-12.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 61 (7)
Canadian Family Physician
Vol. 61, Issue 7
1 Jul 2015
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hepatitis E infection during pregnancy
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hepatitis E infection during pregnancy
Shahnaz A. Chaudhry, Natasha Verma, Gideon Koren
Canadian Family Physician Jul 2015, 61 (7) 607-608;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Hepatitis E infection during pregnancy
Shahnaz A. Chaudhry, Natasha Verma, Gideon Koren
Canadian Family Physician Jul 2015, 61 (7) 607-608;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • During pregnancy
    • Breastfeeding
    • Prevention
    • Conclusion
    • Notes
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • Infection par le virus de l’hépatite E durant la grossesse
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
Show more Practice

Motherisk Update

  • Hepatitis A infection during pregnancy
  • Fluconazole use during breastfeeding
  • Is it safe to breastfeed while taking methylphenidate?
Show more Motherisk Update

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2022 by The College of Family Physicians of Canada

Powered by HighWire